Wed, 9 December 2015
Drs. Ben Solomon, Leora Horn, & Jack West evaluate the merits of broad genetic testing with a "next generation sequencing" platform compared to selective, limited testing for the most proven driver mutations in patients with advanced NSCLC.
Direct download: GRACEcast-411_WCLC_2015_Patients_Benefit_Broad_vs_Focal_Genetic_Testing.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT